Barclays Reiterates Overweight Rating on Strategy (MSTR)
Tweet Send to a Friend
Barclays analyst Ramsey El-Assal reiterated an Overweight rating and $515.00 price target on Strategy (NASDAQ: MSTR)The analyst comments "Key Takeaways ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


